Close

Bioverativ Inc. (BIVV) Tops Q2 EPS by 17c

August 2, 2017 4:51 PM EDT

Bioverativ Inc. (NASDAQ: BIVV) reported Q2 EPS of $0.88, $0.17 better than the analyst estimate of $0.71. Revenue for the quarter came in at $289.1 million versus the consensus estimate of $268 million.

For earnings history and earnings-related data on Bioverativ Inc. (BIVV) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings